APO Research
Talk to an analyst

APO RESEARCH · REPORT

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032

30 December 2025198 pages

Choose your research edition.

Industry ResearchPIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Research Report 2026126 pages · $2,950 USDIndustry Growth & TrendsGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Growth and Trends Forecast to 2032107 pages · $3,450 USDMarket StructureGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Analysis and Forecast 2026-2032198 pages · $4,950 USD

Market perspective

The global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine include Bioveta, Boehringer Ingelheim, CAVAC, Ceva Santé Animale, HIPRA, Jinyu Bio-Technology, Sinopharm Animal Health Co., Ltd, Zoetis and Harbin Pharmaceutical Group, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, projected growth trends, production technology, application and end-user industry.

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Company

Bioveta

Boehringer Ingelheim

CAVAC

Ceva Santé Animale

HIPRA

Jinyu Bio-Technology

Sinopharm Animal Health Co., Ltd

Zoetis

Harbin Pharmaceutical Group

Merck

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Type

CH-1R Strain

PC Strain

Others

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Application

Gilts

Sows

PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. CH-1R Strain Major Manufacturers Table 3. PC Strain Major Manufacturers Table 4. Others Major Manufacturers Table 5. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 6. Gilts Major Manufacturers Table 7. Sows Major Manufacturers Table 8. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends Table 9. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers Table 10. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges Table 11. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints Table 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2026) Table 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2027-2032) Table 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026) & (K Units) Table 19. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032) & (K Units) Table 20. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2026) Table 21. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2027-2032) Table 22. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2021-2026) Table 26. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application Table 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 36. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2026) Table 37. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2027-2032) Table 38. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 40. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 41. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2026) Table 42. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2027-2032) Table 43. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2026) & (US$/Unit) Table 44. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2027-2032) & (US$/Unit) Table 45. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 47. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 48. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2026) Table 49. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2027-2032) Table 50. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 52. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 53. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2026) Table 54. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2027-2032) Table 55. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2026) & (US$/Unit) Table 56. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2027-2032) & (US$/Unit) Table 57. Bioveta Company Information Table 58. Bioveta Business Overview Table 59. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 61. Bioveta Recent Development Table 62. Boehringer Ingelheim Company Information Table 63. Boehringer Ingelheim Business Overview Table 64. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 66. Boehringer Ingelheim Recent Development Table 67. CAVAC Company Information Table 68. CAVAC Business Overview Table 69. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 71. CAVAC Recent Development Table 72. Ceva Santé Animale Company Information Table 73. Ceva Santé Animale Business Overview Table 74. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 76. Ceva Santé Animale Recent Development Table 77. HIPRA Company Information Table 78. HIPRA Business Overview Table 79. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 81. HIPRA Recent Development Table 82. Jinyu Bio-Technology Company Information Table 83. Jinyu Bio-Technology Business Overview Table 84. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 86. Jinyu Bio-Technology Recent Development Table 87. Sinopharm Animal Health Co., Ltd Company Information Table 88. Sinopharm Animal Health Co., Ltd Business Overview Table 89. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 91. Sinopharm Animal Health Co., Ltd Recent Development Table 92. Zoetis Company Information Table 93. Zoetis Business Overview Table 94. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 96. Zoetis Recent Development Table 97. Harbin Pharmaceutical Group Company Information Table 98. Harbin Pharmaceutical Group Business Overview Table 99. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 101. Harbin Pharmaceutical Group Recent Development Table 102. Merck Company Information Table 103. Merck Business Overview Table 104. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio Table 106. Merck Recent Development Table 107. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 108. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 109. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 110. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 111. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 112. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 113. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 114. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 115. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 116. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 117. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 118. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 119. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 120. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 121. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 122. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 123. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 124. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 125. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 126. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 127. United States PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 128. Canada PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 129. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 130. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 131. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 132. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 133. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 134. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 135. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 136. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 137. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 138. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 139. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 140. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 141. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 142. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 143. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 144. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 145. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 146. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 147. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 148. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 149. Germany PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 150. France PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 151. U.K. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Italy PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Netherlands PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 157. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 158. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 159. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 160. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 163. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 164. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 165. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 166. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 169. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 170. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 171. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 172. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 175. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 176. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 177. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 178. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 182. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 183. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 184. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 185. Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 186. Japan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 187. South Korea PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 188. India PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Australia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 190. China Taiwan PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 192. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2026) & (K Units) Table 195. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2027-2032) & (K Units) Table 196. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2021-2026) & (US$/Unit) Table 197. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Type (2027-2032) & (US$/Unit) Table 198. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2026) & (K Units) Table 201. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2027-2032) & (K Units) Table 202. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2021-2026) & (US$/Unit) Table 203. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Application (2027-2032) & (US$/Unit) Table 204. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 208. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021-2026) & (K Units) Table 209. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2027-2032) & (K Units) Table 210. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2021-2026) & (US$/Unit) Table 211. SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Country (2027-2032) & (US$/Unit) Table 212. Brazil PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Argentina PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Chile PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Colombia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Peru PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Israel PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 219. UAE PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Turkey PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Iran PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Egypt PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors List Table 226. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Image Figure 2. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. CH-1R Strain Image Figure 5. PC Strain Image Figure 6. Others Image Figure 7. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 8. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 9. Gilts Image Figure 10. Sows Image Figure 11. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (2021-2032) & (US$ Million) Figure 13. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2032) Figure 16. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales (2021-2032) & (K Units) Figure 17. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales YoY (2021-2032) & (K Units) Figure 20. Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales YoY (2021-2032) & (K Units) Figure 21. China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales YoY (2021-2032) & (K Units) Figure 24. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032) Figure 30. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032) Figure 33. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032) Figure 36. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032) Figure 39. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Type (2021-2032) Figure 40. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Type (2021-2032) Figure 41. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Application (2021-2032) Figure 42. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Application (2021-2032) Figure 43. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Share by Country (2021-2032) Figure 44. North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Share by Country (2021-2032) Figure 45. Europe PIG Porc

Scope & coverage.

Types
  • CH-1R Strain
  • PC Strain
  • Others
Applications
  • Gilts
  • Sows
Companies covered
  • Bioveta
  • Boehringer Ingelheim
  • CAVAC
  • Ceva Santé Animale
  • HIPRA
  • Jinyu Bio-Technology
  • Sinopharm Animal Health Co., Ltd
  • Zoetis
  • Harbin Pharmaceutical Group
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  3. 1.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 CH-1R Strain
  5. 1.2.3 PC Strain
  6. 1.2.4 Others
  7. 1.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  8. 1.3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  9. 1.3.2 Gilts
  10. 1.3.3 Sows
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Dynamics
  1. 2.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Trends
  2. 2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Drivers
  3. 2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Opportunities and Challenges
  4. 2.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region
  3. 3.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region
  9. 3.4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers
  2. 4.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers
  6. 4.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market CR5 and HHI
  16. 4.8.2 2025 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Tier 1, Tier 2, and Tier 3
5 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Type
  1. 5.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type
  2. 5.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type
  6. 5.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type
6 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market by Application
  1. 6.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application
  2. 6.1.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application
  6. 6.2.1 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application
7 Company Profiles
  1. 7.1 Bioveta
  2. 7.1.1 Bioveta Company Information
  3. 7.1.2 Bioveta Business Overview
  4. 7.1.3 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Bioveta PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  6. 7.1.5 Bioveta Recent Developments
  7. 7.2 Boehringer Ingelheim
  8. 7.2.1 Boehringer Ingelheim Company Information
  9. 7.2.2 Boehringer Ingelheim Business Overview
  10. 7.2.3 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Boehringer Ingelheim PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  12. 7.2.5 Boehringer Ingelheim Recent Developments
  13. 7.3 CAVAC
  14. 7.3.1 CAVAC Company Information
  15. 7.3.2 CAVAC Business Overview
  16. 7.3.3 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 CAVAC PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  18. 7.3.5 CAVAC Recent Developments
  19. 7.4 Ceva Santé Animale
  20. 7.4.1 Ceva Santé Animale Company Information
  21. 7.4.2 Ceva Santé Animale Business Overview
  22. 7.4.3 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Ceva Santé Animale PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  24. 7.4.5 Ceva Santé Animale Recent Developments
  25. 7.5 HIPRA
  26. 7.5.1 HIPRA Company Information
  27. 7.5.2 HIPRA Business Overview
  28. 7.5.3 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 HIPRA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  30. 7.5.5 HIPRA Recent Developments
  31. 7.6 Jinyu Bio-Technology
  32. 7.6.1 Jinyu Bio-Technology Company Information
  33. 7.6.2 Jinyu Bio-Technology Business Overview
  34. 7.6.3 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Jinyu Bio-Technology PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  36. 7.6.5 Jinyu Bio-Technology Recent Developments
  37. 7.7 Sinopharm Animal Health Co., Ltd
  38. 7.7.1 Sinopharm Animal Health Co., Ltd Company Information
  39. 7.7.2 Sinopharm Animal Health Co., Ltd Business Overview
  40. 7.7.3 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Sinopharm Animal Health Co., Ltd PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  42. 7.7.5 Sinopharm Animal Health Co., Ltd Recent Developments
  43. 7.8 Zoetis
  44. 7.8.1 Zoetis Company Information
  45. 7.8.2 Zoetis Business Overview
  46. 7.8.3 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Zoetis PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  48. 7.8.5 Zoetis Recent Developments
  49. 7.9 Harbin Pharmaceutical Group
  50. 7.9.1 Harbin Pharmaceutical Group Company Information
  51. 7.9.2 Harbin Pharmaceutical Group Business Overview
  52. 7.9.3 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Harbin Pharmaceutical Group PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  54. 7.9.5 Harbin Pharmaceutical Group Recent Developments
  55. 7.10 Merck
  56. 7.10.1 Merck Company Information
  57. 7.10.2 Merck Business Overview
  58. 7.10.3 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Merck PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Product Portfolio
  60. 7.10.5 Merck Recent Developments
8 North America
  1. 8.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 8.1.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 8.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 8.2.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 8.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 8.3.1 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
9 Europe
  1. 9.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 9.1.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 9.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 9.2.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 9.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 9.3.1 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Netherlands
10 China
  1. 10.1 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 10.1.1 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 10.2 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 10.2.1 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 11.1.1 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 11.2 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 11.2.1 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 11.3 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 11.3.1 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Type
  2. 12.1.1 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Application
  6. 12.2.1 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Market Size by Country
  10. 12.3.1 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Value Chain Analysis
  2. 13.1.1 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Production Mode & Process
  6. 13.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Distributors
  9. 13.2.3 PIG Porcine Reproductive and Respiratory Syndrome (PRRS) Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst